HORIZON-JU-IHI-2022-01-03: Personalised oncology: innovative people centred, multi-modal therapies against cancer

Different treatment modalities are available for various cancers, however, the differing biology of cancers as well as the differing efficacy of treatment modalities dictate rather patient-specific approaches. Multi-modal therapies have been shown to be of high value in this respect and there is a strong need to increase the therapeutic arsenal of such multi-modal therapies and to tailor the treatment approach to the individual patient. The aim of this call topic is biomarker-guided multi-modal precision oncology based on imaging, phenotype, genomics, in vitro diagnostics, co-morbidities, [...]